379 related articles for article (PubMed ID: 30804523)
41. Dietary salt reduction in hypertension--what is the evidence and why is it still controversial?
Chrysant GS; Bakir S; Oparil S
Prog Cardiovasc Dis; 1999; 42(1):23-38. PubMed ID: 10505491
[TBL] [Abstract][Full Text] [Related]
42. Renal denervation and CD161a immune ablation prevent cholinergic hypertension and renal sodium retention.
Raikwar N; Braverman C; Snyder PM; Fenton RA; Meyerholz DK; Abboud FM; Harwani SC
Am J Physiol Heart Circ Physiol; 2019 Sep; 317(3):H517-H530. PubMed ID: 31172810
[TBL] [Abstract][Full Text] [Related]
43. The interplay between Angiotensin II, TLR4 and hypertension.
Biancardi VC; Bomfim GF; Reis WL; Al-Gassimi S; Nunes KP
Pharmacol Res; 2017 Jun; 120():88-96. PubMed ID: 28330785
[TBL] [Abstract][Full Text] [Related]
44. Role of mineralocorticoid action in the brain in salt-sensitive hypertension.
Oki K; Gomez-Sanchez EP; Gomez-Sanchez CE
Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):90-5. PubMed ID: 21585422
[TBL] [Abstract][Full Text] [Related]
45. Infiltrating T lymphocytes in the kidney increase oxidative stress and participate in the development of hypertension and renal disease.
De Miguel C; Guo C; Lund H; Feng D; Mattson DL
Am J Physiol Renal Physiol; 2011 Mar; 300(3):F734-42. PubMed ID: 21159736
[TBL] [Abstract][Full Text] [Related]
46. Salt, Hypertension, and Immunity.
Rucker AJ; Rudemiller NP; Crowley SD
Annu Rev Physiol; 2018 Feb; 80():283-307. PubMed ID: 29144825
[TBL] [Abstract][Full Text] [Related]
47. Contribution of Th17 cells to tissue injury in hypertension.
Basile DP; Abais-Battad JM; Mattson DL
Curr Opin Nephrol Hypertens; 2021 Mar; 30(2):151-158. PubMed ID: 33394732
[TBL] [Abstract][Full Text] [Related]
48. Immune mechanisms in hypertension.
De Ciuceis C; Rossini C; La Boria E; Porteri E; Petroboni B; Gavazzi A; Sarkar A; Rosei EA; Rizzoni D
High Blood Press Cardiovasc Prev; 2014 Dec; 21(4):227-34. PubMed ID: 24446309
[TBL] [Abstract][Full Text] [Related]
49. Pathogenesis of Higher Blood Pressure and Worse Renal Function in Salt-Sensitive Hypertension.
Chu Y; Zhou Y; Lu S; Lu F; Hu Y
Kidney Blood Press Res; 2021; 46(2):236-244. PubMed ID: 33794518
[TBL] [Abstract][Full Text] [Related]
50. Anakinra reduces blood pressure and renal fibrosis in one kidney/DOCA/salt-induced hypertension.
Ling YH; Krishnan SM; Chan CT; Diep H; Ferens D; Chin-Dusting J; Kemp-Harper BK; Samuel CS; Hewitson TD; Latz E; Mansell A; Sobey CG; Drummond GR
Pharmacol Res; 2017 Feb; 116():77-86. PubMed ID: 27986554
[TBL] [Abstract][Full Text] [Related]
51. Different effects of angiotensin receptor blockade on end-organ damage in salt-dependent and salt-independent hypertension.
Maitland K; Bridges L; Davis WP; Loscalzo J; Pointer MA
Circulation; 2006 Aug; 114(9):905-11. PubMed ID: 16923758
[TBL] [Abstract][Full Text] [Related]
52. Role of the adaptive immune system in hypertension.
Harrison DG; Vinh A; Lob H; Madhur MS
Curr Opin Pharmacol; 2010 Apr; 10(2):203-7. PubMed ID: 20167535
[TBL] [Abstract][Full Text] [Related]
53. CCL2 mediates early renal leukocyte infiltration during salt-sensitive hypertension.
Alsheikh AJ; Dasinger JH; Abais-Battad JM; Fehrenbach DJ; Yang C; Cowley AW; Mattson DL
Am J Physiol Renal Physiol; 2020 Apr; 318(4):F982-F993. PubMed ID: 32150444
[TBL] [Abstract][Full Text] [Related]
54. Increased Perfusion Pressure Drives Renal T-Cell Infiltration in the Dahl Salt-Sensitive Rat.
Evans LC; Petrova G; Kurth T; Yang C; Bukowy JD; Mattson DL; Cowley AW
Hypertension; 2017 Sep; 70(3):543-551. PubMed ID: 28696224
[TBL] [Abstract][Full Text] [Related]
55. VEGF-C attenuates renal damage in salt-sensitive hypertension.
Beaini S; Saliba Y; Hajal J; Smayra V; Bakhos JJ; Joubran N; Chelala D; Fares N
J Cell Physiol; 2019 Jun; 234(6):9616-9630. PubMed ID: 30378108
[TBL] [Abstract][Full Text] [Related]
56. Are the innate and adaptive immune systems setting hypertension on fire?
Bomfim GF; Rodrigues FL; Carneiro FS
Pharmacol Res; 2017 Mar; 117():377-393. PubMed ID: 28093357
[TBL] [Abstract][Full Text] [Related]
57. Epigenetic modulation of the renal β-adrenergic-WNK4 pathway in salt-sensitive hypertension.
Mu S; Shimosawa T; Ogura S; Wang H; Uetake Y; Kawakami-Mori F; Marumo T; Yatomi Y; Geller DS; Tanaka H; Fujita T
Nat Med; 2011 May; 17(5):573-80. PubMed ID: 21499270
[TBL] [Abstract][Full Text] [Related]
58. Immune suppression prevents renal damage and dysfunction and reduces arterial pressure in salt-sensitive hypertension.
Tian N; Gu JW; Jordan S; Rose RA; Hughson MD; Manning RD
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H1018-25. PubMed ID: 17040973
[TBL] [Abstract][Full Text] [Related]
59. The modulatory effect of high salt on immune cells and related diseases.
Li X; Alu A; Wei Y; Wei X; Luo M
Cell Prolif; 2022 Sep; 55(9):e13250. PubMed ID: 35747936
[TBL] [Abstract][Full Text] [Related]
60. Protective effect of dietary potassium against cardiovascular damage in salt-sensitive hypertension: possible role of its antioxidant action.
Ando K; Matsui H; Fujita M; Fujita T
Curr Vasc Pharmacol; 2010 Jan; 8(1):59-63. PubMed ID: 19485915
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
